Eugenol

Eugenol

SCHEMBL2467132

C1CC[SiH2]OC1.C=CCc1ccc(O)c(OC)c1.Oc1ccccc1.Oc1ccccc1

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 4/20 0.58
ALDH1A1 P00352 3/20 0.58
CYP3A4 P08684 2/20 0.58
PTGS1 P23219 2/20 0.58
TRPM8 Q7Z2W7 2/20 0.58
AR P10275 1/20 0.58
GABRA1 P14867 3/20 0.46
GABRB2 P47870 3/20 0.46
TDP1 Q9NUW8 3/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
CNR2 P34972 1/20 0.43
PPARA Q07869 2/20 0.43
PPARG P37231 1/20 0.43
PPARD Q03181 1/20 0.43
LMNA P02545 3/20 0.41
KDM4E B2RXH2 3/20 0.41
MAPT P10636 2/20 0.41
TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Eugenol SCHEMBL2243460 0.94 ALOX5 (0.67) ALOX5ALDH1A1CYP3A4PTGS1TRPM8
Phenol SCHEMBL4443494 0.86 XDH (0.40) ALOX5ALDH1A1CYP3A4PTGS1TRPM8
Eugenol SCHEMBL8900744 0.84 ALDH1A1 (0.82) ALOX5ALDH1A1CYP3A4PTGS1TRPM8
Eugenol SCHEMBL5705086 0.84 ALDH1A1 (0.82) ALOX5ALDH1A1CYP3A4PTGS1TRPM8
Chavicol SCHEMBL4444832 0.83 XDH (0.34) ALOX5ALDH1A1CYP3A4GABRA1GABRB2
SCHEMBL3385671 0.80 PTGS1 (0.57) ALDH1A1CYP3A4PTGS1TDP1MEN1
Eugenol SCHEMBL28883151 0.79 ALDH1A1 (0.93) ALOX5ALDH1A1CYP3A4PTGS1TRPM8
SCHEMBL4608373 0.79 XDH (0.45) ALOX5ALDH1A1CYP3A4PTGS1TRPM8
Chavicol SCHEMBL4605750 0.78 XDH (0.38) ALOX5ALDH1A1CYP3A4PTGS1TRPM8
Eugenol SCHEMBL30378957 0.78 ALDH1A1 (0.97) ALOX5ALDH1A1CYP3A4PTGS1TRPM8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1530606-B1 SILOXANE BISCHLOROFORMATES SABIC INNOVATIVE PLASTICS IP (NL) 2010-12-08 EP claimed
CN-101258158-A Siloxane bischloroformates GEN ELECTRIC (US) 2008-09-03 CN claimed
EP-1937693-A1 SILOXANE BISCHLOROFORMATES General Electric Company (US) 2008-07-02 EP claimed
CN-1324071-C Siloxane bischloroformates GEN ELECTRIC (US) 2007-07-04 CN claimed
US-20070093629-A1 Siloxane bishchloroformates GENERAL ELECTRIC COMPANY (US) 2007-04-26 US claimed
WO-2007037888-A1 SILOXANE BISCHLOROFORMATES GENERAL ELECTRIC COMPANY (US) 2007-04-05 WO claimed
CN-1688634-A Siloxane bischloroformates GEN ELECTRIC (US) 2005-10-26 CN claimed
EP-1530606-A1 SILOXANE BISCHLOROFORMATES GENERAL ELECTRIC COMPANY (US) 2005-05-18 EP claimed
US-6780956-B2 FOR CONTROLLING PHYSICAL PROPERTIES OF POLYCARBONATESILOXANE COPOLYMERS; FOR PRODUCTION OF OPTICAL DISKS GENERAL ELECTRIC COMPANY 2004-08-24 US claimed
US-20040133024-A1 Siloxane bischloroformates SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2004-07-08 US claimed
US-6723864-B2 CONTINUOUS PROCESS BY PHOSGENATING SILOXANE BISPHENOLS IN A FLOW REACTOR USING A SUBSTANTIAL EXCESS OF PHOSGENE AND SODIUM HYDROXIDE GENERAL ELECTRIC COMPANY 2004-04-20 US claimed
WO-2004016675-A1 SILOXANE BISCHLOROFORMATES GENERAL ELECTRIC COMPANY (US) 2004-02-26 WO claimed
US-20040039218-A1 A continuous process by phosgenating siloxane bisphenols in a flow reactor using a substantial excess of phosgene and sodium hydroxide to achieve high yields and very pure product; intermediates for polycarbonatesiloxanes GENERAL ELECTRIC COMPANY 2004-02-26 US claimed
US-20030065122-A1 Method of making silicone copolycarbonates having random and blocky substructures GENERAL ELECTRIC COMPANY 2003-04-03 US claimed
US-6492481-B1 THE SILICONE COPOLYCARBONATES CONTAIN RESIDUES OF SILICONE CONTAINING AND NONSILICONE CONTAINING BISPHENOLS AND HAVE PROPERTIES PARTICULARLY SUITED FOR USE IN HIGH DENSITY OPTICAL DATA STORAGE MEDIA. THE PROPERTIES OF SUBSTANTIALLY SINGLE GENERAL ELECTRIC COMPANY 2002-12-10 US claimed
EP-1235872-A1 SUBSTANTIALLY SINGLE PHASE SILICONE COPOLYCARBONATES, METHODS, AND OPTICAL ARTICLES MADE THEREFROM GENERAL ELECTRIC COMPANY (US) 2002-09-04 EP claimed
WO-2002004545-A1 SUBSTANTIALLY SINGLE PHASE SILICONE COPOLYCARBONATES, METHODS, AND OPTICAL ARTICLES MADE THEREFROM GENERAL ELECTRIC COMPANY (US) 2002-01-17 WO claimed
EP-1963399-B1 POLYCYCLIC DIHYDROXY COMPOUNDS AND METHODS FOR PREPARATION SABIC GLOBAL TECHNOLOGIES BV (NL) 2016-07-27 EP disclosed
EP-1235872-A1 SUBSTANTIALLY SINGLE PHASE SILICONE COPOLYCARBONATES, METHODS, AND OPTICAL ARTICLES MADE THEREFROM GENERAL ELECTRIC COMPANY (US) 2002-09-04 EP disclosed
WO-2002004545-A1 SUBSTANTIALLY SINGLE PHASE SILICONE COPOLYCARBONATES, METHODS, AND OPTICAL ARTICLES MADE THEREFROM GENERAL ELECTRIC COMPANY (US) 2002-01-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040133024-A1 Siloxane bischloroformates PSMA2, PSMA3, PSMA4 ALOX5 2032/4885ALDH1A1 3970/4885CYP3A4 848/4885
US-20040039218-A1 A continuous process by phosgenating siloxane bisphenols in a flow reactor using a substantial excess of phosgene and sodium hydroxide to achieve high yields and very pure product; intermediates for polycarbonatesiloxanes PSPH, PAH, SEM1 ALOX5 1919/4885ALDH1A1 4036/4885CYP3A4 494/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.